Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
Ganna Chornokur(Moffitt Cancer Center), Rosalind Glasspool(Institut Bergonié), Brooke L. Fridley(Children's Mercy Hospital), Maria Bisogna(Memorial Sloan Kettering Cancer Center), Julie M. Cunningham(Cancer Research UK), Katja K.H. Aben(Radboud University Nijmegen), Y. Ann Chen(Zhejiang Chinese Medical University), Yukie T. Bean(Oregon Health & Science University), Elisa V. Bandera(Rutgers, The State University of New Jersey), Ralf Bützow(Helsinki University Hospital), Linda S. Cook, Jonathan P. Tyrer(University of Cambridge), Natalia Bogdanova(Medizinische Hochschule Hannover), Peter A. Fasching(Universitätsklinikum Erlangen), Graham G. Giles(The University of Melbourne), Line Bjørge(Haukeland University Hospital), Fiona Bruinsma(Cancer Council Victoria), Thilo Dörk(Hannover Re (Germany)), Hui‐Yi Lin(Moffitt Cancer Center), Joe Dennis(University of Cambridge), Agnieszka Dansonka‐Mieszkowska(University of Cambridge), Ian Campbell(The University of Sydney), Matthias W. Beckmann(Universitätsklinikum Erlangen), Arif B. Ekici(University Medical Center Groningen), Heather Jim(Moffitt Cancer Center), Andreas du Bois(Kliniken Essen-Mitte), Ya-Yu Tsai(Moffitt Cancer Center), Douglas F. Easton(University of Cambridge), Aleksandra Gentry‐Maharaj(UCL Australia), Ed Dicks(Institute of Cancer Research), Karen Carty(Cancer Research UK Clinical Trials Unit), Evelyn Despierre(KU Leuven), Jennifer Permuth‐Wey(Moffitt Cancer Center), Daniel W. Cramer(Brigham and Women's Hospital), Louise A. Brinton(National Cancer Institute), Kate Lawrenson(Texas A&M University – San Antonio), Jennifer A. Doherty(Cancer Prevention Institute of California), Hoda Anton‐Culver(University of California, Irvine), Ernest K. Amankwah(Johns Hopkins University), Yu‐Tang Gao(Renji Hospital), Matthias Dürst(Jena University Hospital), Cezary Cybulski(International Hereditary Cancer Center), Zhihua Chen(Shanghai University), Natalia Antonenkova(N.N. Alexandrov National Cancer Centre), Jenny Chang‐Claude(Universität Hamburg), Xiaotao Qu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Clareann H. Bunker(University College London Hospitals NHS Foundation Trust), Robert P. Edwards(Magee-Womens Research Institute), Angela Brooks‐Wilson(BC Cancer Agency)
Cited by 906
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Patterns of somatic mutation in human cancer genomes
|Nature|2007|3.1k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index
|Nature Genetics|2010|3k